-
STARTRADER Launches XAUUSD247, Extending Gold CFD Access Across the Full Week
-
Premier League returns with Arsenal eyeing title dynasty
-
Spurs agree deal to sign Man City's Savinho: reports
-
Bayern knew about Musiala's condition 'a long time ago' says Kompany
-
US-sanctioned ICC head warns against 'demise of international rule of law'
-
Ex-Pakistan PM Khan taken back to jail after hospital checks
-
Top India court orders new steps to protect threatened elephants
-
Real Madrid star players are compatible: Mourinho
-
Djibouti football federation accused of misusing funds
-
Drovix Launches In-House Multi-Asset Liquidity and Execution Stack for Sub-Millisecond Fills, Tighter Spreads
-
Australia charges man with trying to pass Ukraine military intel to Russia
-
'So bad it's good': rough animated film becomes surprise Chinese hit
-
Ex-Pakistan PM Khan taken back to jail after hospital checks: govt
-
'I'll adapt': First pregnant candidate navigates French presidential race
-
China, Indonesia hold talks on security, defence
-
Hong Kong convicts Tiananmen vigil activists of inciting subversion
-
Train to nowhere? South Korea's lonely push for peace with the North
-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
Kiwi Ears Stardust: The Art of Natural Balance
-
IRA-Eligible Gold: Rules, Approved Coins, and Best Gold Dealers (Guide Released)
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
Featured
Last news
Annealsys Streamlines Scientific Product Evaluation with Customized Bioz Badges
PALO ALTO, CA / ACCESS Newswire / July 29, 2026 / Bioz, Inc., the world's most advanced platform that aids suppliers in leveraging scientific literature to strengthen product discovery and validation, is proud to showcase its partnership with Annealsys, a leading manufacturer of Rapid Thermal Processing (RTP) and Direct Liquid Injection (DLI-CVD and DLI-ALD) deposition systems for research and production applications.
Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update
Collaboration with Vilnius University Hospital Santaros Klinikos on HG-CT-1 Clinical Application and Research
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 29
LONDON, UK / ACCESS Newswire / July 29, 2026 / The Company announces that on 28 July 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Ferris Optical Inc. Expands Access to Affordable Used Ophthalmic Equipment for Eye Clinics Worldwide
Ferris Optical helps optometrists, ophthalmologists, and clinic owners find used ophthalmic equipment from top brands at more affordable prices.
Two dead in shopping mall hit by Japan quake
Two young women were found dead early Wednesday in a mall badly damaged by a powerful earthquake and subsequent explosion in Japan, local media reported, as crews continued searching for missing people.
France needs more Canadair water bombers but building them is painfully slow
As French firefighters struggle to contain the worst wildfires in living memory with just 12 aerial water bombers, production of the iconic aircraft creaks along half a world away in a Canadian factory.
Many feared trapped in quake-hit Japan mall
Emergency responders searched early Wednesday for people feared trapped in a shopping mall in Japan after a major earthquake toppled buildings, sparked fires and reportedly killed one person and injured more than 100.
Dozens feared trapped in quake-hit Japan mall
Dozens of people were feared trapped in a shopping mall in Japan on Tuesday after a major earthquake toppled buildings, sparked fires and reportedly killed one person and injured more than 100.
'Many people' feared trapped in mall after big Japan quake
"Many people" were feared trapped in a stricken shopping mall in Japan late on Tuesday, authorities said, after a major earthquake toppled buildings, sparked fires and reportedly injured more than 100.
Anglican Church leader visits slave trade project on Africa tour
The head of the Church of England Sarah Mullally has visited an Anglican-led project in Ghana on the transatlantic slave trade and met the country's president as part of an African tour.
Japan PM says injuries, buildings collapsed in major quake
A major earthquake collapsed buildings and sparked fires in Japan's southwest, Prime Minister Sanae Takaichi said on Tuesday, with broadcaster NHK saying that at least 50 people were taken to hospital.
Firefighters on offensive in France, Spain as new heatwave arrives
Firefighters in France and Spain rushed to contain the worst wildfires in living memory on Tuesday, seizing crucial hours before the arrival of another wave brings scorching temperatures.
Myanmar approves death sentence for cyberscam offences
Myanmar's military-backed parliament approved a law on Tuesday that authorises capital punishment for those who detain or violently coerce victims into working in online scam centres, the speaker said.
Black Book: 2027 Budgets Pivot to Healthcare Supply Chain Control Towers and Outcome-Based Managed Services
Seventy-six percent expect orchestration to become a funded strategic priority by 2028 as supplier-risk transparency, substitution automation and service accountability move into buying contracts
Nepra Foods Executes Definitive Agreement to Acquire Idaho Beverage Manufacturing Business
Transaction marks a significant milestone in the Company's evolution into a more diversified domestic food and beverage business.
Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c
News Release Highlights:U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances.Vanta has established a strategic operating framework supporting its contemplated U.S. peptide platform, including telehealth-enabled commercialization, FDA-registered compounding pharmacy coordination, peptide manufacturing and fulfillment capabilities, and compliant payment processing infrastructure.Vanta continues advancing its strategy to build an integrated U.S.-focused consumer health sciences platform combining contemplated peptide therapies with its existing nutraceutical and premium functional hydration portfolio, positioning the Company to participate in the longevity and preventative wellness market.
Envela to Announce Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
IRVING, TX / ACCESS Newswire / July 28, 2026 / Envela Corporation ("Envela" or the "Company") announced today that it plans to report its financial results for the second quarter of 2026 after the market close on Wednesday, August 5, 2026.
Supporting Rural Health Through Innovative Technology
By Rebecca VandeKieft, Vice President & General Manager of Emergency Services, Avel eCare
NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals
Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies.
Karviva Founder Dr. Angela Zeng Releases Debut Book The Balance Cure
New book introduces Dr. Angela Zeng's perspective on Traditional Chinese Medicine and contemporary nutrition.
Black Book: Healthcare Supply Chain IT Emerges as One of 2027’s Hottest Technology Markets
Q3 2026 benchmark expands to 36 categories as health systems accelerate investment in automation, resilience, product intelligence, robotics and managed operations
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogsJaguar expects to make Neonorm Dog available through both Amazon and Chewy
Newsmax and Meta Enter AI Content Partnership
BOCA RATON, FL / ACCESS Newswire / July 28, 2026 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") announced today that the Company has entered into an AI content partnership with Meta Platforms ("Meta").
Dolphin Entertainment Subsidiaries Powered High-Profile Campaigns at San Diego Comic-Con 2026
The Agency Collective Executed Publicity, Experiential Marketing and Digital Campaigns for Major Film Releases, Television Franchises and Leading Fan-First Consumer Brands
Medical Care Technologies Inc. (OTC PINK:MDCE) Leapfrogs Prior Patent with Next-Gen Continuously Learning AI Vision Models
Technical Progression Positions MDCE's Vision Platform for Higher-Value Enterprise Deployments While Maintaining Core Strengths
New to The Street's Esteemed Client Virtuix (NASDAQ: VTIX) Advances AI and Robotics Strategy with Initial Sale to Tesla's Optimus Division
Latest Milestone Builds on Virtuix's Growing Presence Across U.S. Defense, NASA, Enterprise AI, and Next-Generation Robotics Applications
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value.
NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial
SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it is eagerly awaiting regulatory approval to begin a Phase II Clinical Trial of NV-387 Oral Gummies, after having filed an application to the local regulatory agency ACOREP, as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company explains that it has already raised the financing to support this clinical trial.
374Water's Mobile AirSCWO System Completes Phase 2 of the St. Cloud, MN Mobile AirSCWO Deployment; Begins Phase 3
Successful Class A biosolids campaign advances the State of Minnesota's evaluation of AirSCWO for permanent PFAS destruction
Author Evgueniy Todorov Releases Odin's Baked Goods: A Whimsical, Research-Backed Retelling of Norse Myths and Viking Sagas
ALEXANDRIA, VA / ACCESS Newswire / July 28, 2026 / First and foremost, this book is not a cookbook. You will find no recipes here in spite of the title. Baking is a metaphor for life and creation, re-telling the old myths, the Viking sagas and historic events with sparkling humor and whimsical use of baking terminology.
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
FORT LAUDERDALE, FL / ACCESS Newswire / July 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Ondansetron tablets of 4mg and 8mg for the Canadian market. Ondansetron is the generic equivalent of the brand name, Zofran®.
Black Book: Healthcare Supply Chain IT Enters a 2027 Replacement Supercycle as 71% Plan Major Upgrades
Nine in ten surveyed healthcare leaders rank supply chain among their top three non-labor financial levers, while 74% require measurable value from new platforms within 12 months